Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 2 Feb 24 S-1/A IPO registration (amended)
- 12 Dec 23 S-1/A IPO registration (amended)
- 28 Aug 23 S-1/A IPO registration (amended)
- 17 Jul 23 S-1/A IPO registration (amended)
-
29 Jun 23 S-1/A IPO registration (amended)
- 2 Jun 23 S-1/A IPO registration (amended)
- 8 May 23 S-1/A IPO registration (amended)
- 3 Nov 22 S-1/A IPO registration (amended)
- 9 Sep 22 S-1 IPO registration
VTRO similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement on Form S-1 (Amendment No. 4) of our report dated January 30, 2023, except for Note 5 which is dated June 2, 2023, with respect to the audited financial statements of Vitro Biopharma Inc. and its subsidiaries for the years ended October 31, 2022 and 2021. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the references to us under the heading “Experts” in such Registration Statement.
/s/ MaloneBailey, LLP
www.malonebailey.com
Houston, Texas
June 29, 2023